Loading...
Loading...
PAVMW| Name | Value |
|---|---|
| Revenues | 1.0M |
| Cost of Revenue | 2.0M |
| Gross Profit | -1.0M |
| Operating Expense | 12.7M |
| Operating I/L | -13.7M |
| Other Income/Expense | -1.2M |
| Interest Income | 0.1M |
| Pretax | -14.9M |
| Income Tax Expense | 0.0M |
| Net Income/Loss | -10.8M |
PAVmed Inc. is a US-based medical device company specializing in innovative products for various medical conditions. Its lead products include CarpX, a percutaneous device for carpal tunnel syndrome, and EsoCheck, an esophageal cell collection device for early cancer detection. The company's product pipeline also features EsoGuard, a molecular diagnostic esophageal DNA test, and EsoCure, an esophageal ablation device. Additionally, it offers PortIO, an implantable intraosseous vascular access device, NextFlo disposable infusion platform technology, and DisappEAR, a resorbable pediatric ear tube. PAVmed Inc. generates revenue through the sale of these medical devices and related services.
